DE69915110D1 - Verfahren zur herstellung von arylethern - Google Patents

Verfahren zur herstellung von arylethern

Info

Publication number
DE69915110D1
DE69915110D1 DE69915110T DE69915110T DE69915110D1 DE 69915110 D1 DE69915110 D1 DE 69915110D1 DE 69915110 T DE69915110 T DE 69915110T DE 69915110 T DE69915110 T DE 69915110T DE 69915110 D1 DE69915110 D1 DE 69915110D1
Authority
DE
Germany
Prior art keywords
arylethers
production
epoxide
oxidizing
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69915110T
Other languages
English (en)
Other versions
DE69915110T2 (de
Inventor
E Henegar
Elizabeth Mancini
Douglas Maisto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of DE69915110D1 publication Critical patent/DE69915110D1/de
Application granted granted Critical
Publication of DE69915110T2 publication Critical patent/DE69915110T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66Methanesulfonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69915110T 1998-12-29 1999-12-23 Verfahren zur herstellung von arylethern Expired - Fee Related DE69915110T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11409298P 1998-12-29 1998-12-29
US114092P 1998-12-29
PCT/US1999/030748 WO2000039072A1 (en) 1998-12-29 1999-12-23 Method for the preparation of aryl ethers

Publications (2)

Publication Number Publication Date
DE69915110D1 true DE69915110D1 (de) 2004-04-01
DE69915110T2 DE69915110T2 (de) 2004-08-26

Family

ID=22353332

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69940833T Expired - Fee Related DE69940833D1 (de) 1998-12-29 1999-12-23 Verfahren zur Herstellung von Arylethern
DE69915110T Expired - Fee Related DE69915110T2 (de) 1998-12-29 1999-12-23 Verfahren zur herstellung von arylethern

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69940833T Expired - Fee Related DE69940833D1 (de) 1998-12-29 1999-12-23 Verfahren zur Herstellung von Arylethern

Country Status (24)

Country Link
US (1) US6376711B1 (de)
EP (2) EP1308443B1 (de)
JP (1) JP2002533430A (de)
KR (2) KR100616029B1 (de)
CN (3) CN100340552C (de)
AT (2) ATE260238T1 (de)
AU (1) AU764492B2 (de)
BR (1) BR9916615A (de)
CA (1) CA2349619A1 (de)
CO (1) CO5140125A1 (de)
DE (2) DE69940833D1 (de)
DK (1) DK1140788T3 (de)
ES (1) ES2214060T3 (de)
HK (3) HK1041688B (de)
HU (1) HUP0202144A3 (de)
IL (2) IL144012A (de)
NZ (1) NZ511452A (de)
PE (1) PE20001366A1 (de)
PT (1) PT1140788E (de)
SI (1) SI1140788T1 (de)
TR (1) TR200101885T2 (de)
TW (1) TWI238155B (de)
WO (1) WO2000039072A1 (de)
ZA (1) ZA200103532B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796069B3 (fr) * 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
AR030284A1 (es) * 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
CN1922124A (zh) * 2004-02-20 2007-02-28 法玛西雅厄普约翰公司 制备芳基醚的方法
WO2005082869A1 (en) * 2004-02-20 2005-09-09 Pharmacia & Upjohn Company Llc Method for the preparation of aryl ethers
WO2005095435A1 (ja) * 2004-03-31 2005-10-13 Kuraray Co., Ltd. プレグナン誘導体の製造方法
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
PT2076508E (pt) 2006-10-18 2011-03-07 Pfizer Prod Inc Compostos de ureia de éter biarílico
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
CN103804316A (zh) * 2012-11-13 2014-05-21 天津药物研究院 一种(2RS,3RS)-6-[a-(2-乙氧基苯氧基)苄基]吗啉-3-酮(Ⅰ)的制备方法
CN104557936A (zh) * 2015-01-15 2015-04-29 河南科技学院 一种新型手性非环嘌呤核苷类似物的合成方法
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785185A (en) * 1952-08-07 1957-03-12 Union Carbide & Carbon Corp Process for making oxirane compounds from olefins and aldehyde monoperacylates
GB1053972A (de) * 1962-08-30 1967-01-04
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) * 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane

Also Published As

Publication number Publication date
KR20010099999A (ko) 2001-11-09
JP2002533430A (ja) 2002-10-08
ES2214060T3 (es) 2004-09-01
CN1636988A (zh) 2005-07-13
AU2381900A (en) 2000-07-31
ZA200103532B (en) 2002-08-02
CN1308332C (zh) 2007-04-04
ATE430144T1 (de) 2009-05-15
KR20060090310A (ko) 2006-08-10
CO5140125A1 (es) 2002-03-22
CN1249038C (zh) 2006-04-05
AU764492B2 (en) 2003-08-21
IL144012A (en) 2005-11-20
BR9916615A (pt) 2001-10-23
CN1332719A (zh) 2002-01-23
HUP0202144A3 (en) 2003-10-28
HK1078572A1 (en) 2006-03-17
CA2349619A1 (en) 2000-07-06
IL144012A0 (en) 2002-04-21
EP1308443A3 (de) 2003-10-01
DE69940833D1 (de) 2009-06-10
NZ511452A (en) 2002-11-26
HK1066004A1 (en) 2005-03-11
TWI238155B (en) 2005-08-21
PE20001366A1 (es) 2000-11-19
KR100616029B1 (ko) 2006-08-28
ATE260238T1 (de) 2004-03-15
SI1140788T1 (en) 2004-08-31
US6376711B1 (en) 2002-04-23
IL161840A0 (en) 2005-11-20
CN100340552C (zh) 2007-10-03
WO2000039072A1 (en) 2000-07-06
HK1041688A1 (en) 2002-07-19
PT1140788E (pt) 2004-07-30
KR100616386B1 (ko) 2006-08-28
EP1140788B1 (de) 2004-02-25
EP1308443B1 (de) 2009-04-29
EP1140788A1 (de) 2001-10-10
HK1041688B (zh) 2007-12-07
CN1532194A (zh) 2004-09-29
HUP0202144A2 (hu) 2002-11-28
DE69915110T2 (de) 2004-08-26
TR200101885T2 (tr) 2002-01-21
DK1140788T3 (da) 2004-06-07
EP1308443A2 (de) 2003-05-07

Similar Documents

Publication Publication Date Title
HK1078572A1 (en) Method for the preparation of aryl ethers
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
DE69231815T2 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
DE69931493D1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
DE50005649D1 (de) Verfahren zur Herstellung von Alkylphosphonsäuren
DE60125378D1 (de) Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen
DE69910101D1 (de) Verfahren zur Herstellung von Opiaten
ATE355296T1 (de) Verfahren zur herstellung von (e,z) 3-(2- aminoethoxyimino)-androstane-6,17-dione und analoge
DE50209620D1 (de) Verfahren zur Herstellung von kristallinem Cholinascorbat
ATE271561T1 (de) Verfahren zur herstellung von einer amid verbindung
ATE231856T1 (de) Verfahren zur herstellung von omeprazol
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE46166T1 (de) Verfahren zur herstellung von epoxidierten organoalkoxysiliziumverbindungen.
ATE265421T1 (de) Verfahren zur herstellung von midodrin
ATE417814T1 (de) Verfahren zur herstellung von tetracarbonsäuren
ATE365706T1 (de) Verfahren zur herstellung von bis (trifluormethyl)imido-salzen
DE60028998T8 (de) Verfahren zur herstellung einer benzylamin-verbindung
DE69733716D1 (de) Verfahren zur herstellung von imidazolderivaten
DE50213141D1 (de) Verfahren zur Herstellung von Glycinderivaten
DE60034699D1 (de) Verfahren zur herstellung von fumagillin
DE50203367D1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
DE69816773D1 (de) Verfahren zur herstellung von 1,4-benzodioxan-derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee